Sunshine Heart (NASDAQ:SSH) is developing a medical device that could revolutionize how Class III/IV Congestive Heart Failure (CHF) patients are treated. The medical device is called C-Pulse, and was invented by the co-founder of the company, Dr.
EDEN PRAIRIE, Minn., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today that the company is scheduled to present a corporate update at the following upcoming investor conferences for the balance of 2014:.
Sunshine Heart Inc. (SSH - Snapshot Report) was a big mover last session with its shares rising over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.
Sunshine Heart, Inc. (NASDAQ:SSH) announced today the pricing of its previously announced offering of 3,810,000 shares of its common stock at a price to the public of $10.50 per share in an underwritten public offering to raise $40M.
EDEN PRAIRIE, Minn., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) today provided a clarification of information covered during its October 30, 2014 third quarter financial results conference call.
EDEN PRAIRIE, Minn., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) today announced that its third quarter 2014 results will be released on Thursday, October 30, 2014, before the open of the stock market.